Skip to main content
. 2015 Jan 31;10:31. doi: 10.1186/s13014-015-0337-4

Figure 1.

Figure 1

The overall survival rates of the ESD-CRT (n = 16) and dCRT (n = 31) patients. ESD-CRT: endoscopic submucosal dissection + chemoradiotherapy; dCRT: definitive chemoradiotherapy. The 3-year overall survival rate of the dCRT group (63.2%) was lower but not significantly different (p = 0.118) from that of the ESD-CRT group (90.0%).